UTI Statistics
Total Valuation
UTI has a market cap or net worth of $1.91 billion. The enterprise value is $2.03 billion.
| Market Cap | 1.91B |
| Enterprise Value | 2.03B |
Important Dates
The next estimated earnings date is Tuesday, August 5, 2025, after market close.
| Earnings Date | Aug 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
UTI has 54.41 million shares outstanding. The number of shares has increased by 37.92% in one year.
| Current Share Class | 54.41M |
| Shares Outstanding | 54.41M |
| Shares Change (YoY) | +37.92% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 2.72% |
| Owned by Institutions (%) | 87.97% |
| Float | 52.92M |
Valuation Ratios
The trailing PE ratio is 33.73 and the forward PE ratio is 37.32. UTI's PEG ratio is 2.49.
| PE Ratio | 33.73 |
| Forward PE | 37.32 |
| PS Ratio | 2.42 |
| Forward PS | 2.21 |
| PB Ratio | 6.48 |
| P/TBV Ratio | 7.69 |
| P/FCF Ratio | 26.88 |
| P/OCF Ratio | 19.11 |
| PEG Ratio | 2.49 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.55, with an EV/FCF ratio of 28.58.
| EV / Earnings | 35.28 |
| EV / Sales | 2.59 |
| EV / EBITDA | 18.55 |
| EV / EBIT | 25.99 |
| EV / FCF | 28.58 |
Financial Position
The company has a current ratio of 1.07, with a Debt / Equity ratio of 0.87.
| Current Ratio | 1.07 |
| Quick Ratio | 0.90 |
| Debt / Equity | 0.87 |
| Debt / EBITDA | 1.59 |
| Debt / FCF | 3.62 |
| Interest Coverage | 10.06 |
Financial Efficiency
Return on equity (ROE) is 21.81% and return on invested capital (ROIC) is 8.81%.
| Return on Equity (ROE) | 21.81% |
| Return on Assets (ROA) | 6.85% |
| Return on Invested Capital (ROIC) | 8.81% |
| Return on Capital Employed (ROCE) | 14.56% |
| Revenue Per Employee | $211,538 |
| Profits Per Employee | $15,520 |
| Employee Count | 3,700 |
| Asset Turnover | 1.10 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, UTI has paid $19.07 million in taxes.
| Income Tax | 19.07M |
| Effective Tax Rate | 24.93% |
Stock Price Statistics
The stock price has increased by +129.64% in the last 52 weeks. The beta is 1.62, so UTI's price volatility has been higher than the market average.
| Beta (5Y) | 1.62 |
| 52-Week Price Change | +129.64% |
| 50-Day Moving Average | 30.25 |
| 200-Day Moving Average | 24.30 |
| Relative Strength Index (RSI) | 60.53 |
| Average Volume (20 Days) | 1,132,668 |
Short Selling Information
The latest short interest is 1.60 million, so 2.93% of the outstanding shares have been sold short.
| Short Interest | 1.60M |
| Short Previous Month | 2.21M |
| Short % of Shares Out | 2.93% |
| Short % of Float | 3.02% |
| Short Ratio (days to cover) | 1.86 |
Income Statement
In the last 12 months, UTI had revenue of $782.69 million and earned $57.42 million in profits. Earnings per share was $1.04.
| Revenue | 782.69M |
| Gross Profit | 438.10M |
| Operating Income | 77.95M |
| Pretax Income | 40.10M |
| Net Income | 57.42M |
| EBITDA | 109.23M |
| EBIT | 77.95M |
| Earnings Per Share (EPS) | $1.04 |
Balance Sheet
The company has $136.21 million in cash and $256.93 million in debt, giving a net cash position of -$120.73 million or -$2.22 per share.
| Cash & Cash Equivalents | 136.21M |
| Total Debt | 256.93M |
| Net Cash | -120.73M |
| Net Cash Per Share | -$2.22 |
| Equity (Book Value) | 293.91M |
| Book Value Per Share | 5.40 |
| Working Capital | 13.35M |
Cash Flow
In the last 12 months, operating cash flow was $99.72 million and capital expenditures -$28.83 million, giving a free cash flow of $70.89 million.
| Operating Cash Flow | 99.72M |
| Capital Expenditures | -28.83M |
| Free Cash Flow | 70.89M |
| FCF Per Share | $1.30 |
Margins
Gross margin is 55.97%, with operating and profit margins of 9.96% and 7.34%.
| Gross Margin | 55.97% |
| Operating Margin | 9.96% |
| Pretax Margin | 9.77% |
| Profit Margin | 7.34% |
| EBITDA Margin | 13.96% |
| EBIT Margin | 9.96% |
| FCF Margin | 9.06% |
Dividends & Yields
UTI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -37.92% |
| Shareholder Yield | -37.92% |
| Earnings Yield | 3.01% |
| FCF Yield | 3.72% |
Analyst Forecast
The average price target for UTI is $34.83, which is -0.54% lower than the current price. The consensus rating is "Strong Buy".
| Price Target | $34.83 |
| Price Target Difference | -0.54% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
UTI has an Altman Z-Score of 3.12 and a Piotroski F-Score of 8.
| Altman Z-Score | 3.12 |
| Piotroski F-Score | 8 |